2025
SJR Q2
JCR Q3 · 2
OA
4 matched articles
ESCI
Journal detail
Journal of Ophthalmic Inflammation and Infection
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
18695760
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,691
- Quartile Q2
- H-Index 43
- Cites/doc 2,11
- Docs (3y) 165
- Cites (3y) 377
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 2
- JCI 0,77
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Infectious Diseases Q2
- Ophthalmology Q2
Areas
- Medicine
WoS categories
- Ophthalmology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,691 | 2 | 2 | 0,77 | Q2 | 43 |
| 2024 | Q2 | Q2 | 0,787 | 2,3 | 2,4 | 0,97 | Q2 | 40 |
| 2023 | Q2 | Q1 | 0,749 | 2,9 | 2,7 | 1,01 | Q2 | 40 |
| 2022 | Q2 | — | 0,607 | 2,9 | 2,9 | 0,84 | Q2 | 40 |
| 2021 | Q2 | — | 0,708 | — | — | 0,6 | Q3 | 40 |
| 2020 | Q2 | — | 0,821 | — | — | 0,69 | Q3 | 40 |
| 2019 | Q3 | — | 0,477 | — | — | — | — | 40 |
| 2017 | Q2 | — | 0,583 | — | — | — | — | 40 |
| 2016 | Q2 | — | 0,729 | — | — | — | — | 40 |
| 2015 | Q1 | — | 0,943 | — | — | — | — | 40 |
| 2014 | Q2 | — | 0,58 | — | — | — | — | 40 |
| 2013 | Q2 | — | 0,608 | — | — | — | — | 40 |
| 2012 | Q2 | — | 0,408 | — | — | — | — | 40 |
| 2011 | — | — | — | — | — | — | — | 40 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | OPHTHALMOLOGY | ESCI | Q3 | Q2 | 55/98 |
| 2024 | OPHTHALMOLOGY | ESCI | Q2 | Q2 | 31/99 |
| 2023 | OPHTHALMOLOGY | ESCI | Q1 | Q2 | 21/95 |
| 2022 | OPHTHALMOLOGY | ESCI | — | Q2 | — |
| 2021 | OPHTHALMOLOGY | ESCI | — | Q3 | — |
| 2020 | OPHTHALMOLOGY | ESCI | — | Q3 | — |